AgTalk Home
AgTalk Home
Search Forums | Classifieds (112) | Skins | Language
You are logged in as a guest. ( logon | register )

COVID Vaccine “Safe and Effective” Narrative Collapses on Camera
View previous thread :: View next thread
   Forums List -> Kitchen TableMessage format
 
HuskerJ
Posted 5/28/2025 17:09 (#11241781 - in reply to #11234053)
Subject: RE: COVID Vaccine “Safe and Effective” Narrative Collapses on Camera



East of Broken Bow
There are lots of sources that say that all cause of death for people taking the Pfizer covid vaxx is higher than unvaxxed people one of which is an official FDA report.

Also, lots of sources that say the Moderna version is/was much safer.


https://www.israelnationalnews.com/news/317091

The clinical trials of Pfizer’s coronavirus vaccine found that the all-cause mortality rate of the vaccinated group was higher than that of the control group, months after the trials were launched, according to a recently released FDA report.

According to the report, which was released by the US Food and Drug Administration to provide background information on its August 2021 decision to grant full approval for the Pfizer-BioNTech coronavirus vaccine after offering limited emergency authorization of use in last December, six months after the vaccine’s clinical trial began, the total number of deaths reported in the vaccinated group was nearly one-quarter higher than the number of deaths in the placebo group.


----if you go to the above article, it has a link to the actual report cited, which includes the raw data that was used to compile the stats.--



https://www.medrxiv.org/content/10.1101/2025.04.25.25326460v1


Main outcome measures All-cause, cardiovascular, COVID-19, and non-COVID-19 mortality within 12 months after the second COVID-19 vaccine dose

Results There were 9,162,484 noninstitutionalized adult Florida residents who met inclusion criteria, including 5,328,226 BNT162b2 vaccine recipients and 3,834,258 mRNA-1273 vaccine recipients. A total of 1,470,100 vaccinees were matched 1-to-1 based on seven criteria, including census tract. Compared with mRNA-1273 recipients, BNT162b2 recipients had significantly higher risk for all-cause mortality (847.2 vs. 617.9 deaths per 100,000; odds ratio, OR [95% CI]: 1.384 [1.331, 1.439]), cardiovascular mortality (248.7 vs. 162.4 deaths per 100,000 persons; OR [95% CI]: 1.540 [1.431, 1.657]), COVID-19 mortality (55.5 vs. 29.5 deaths per 100,000 persons; OR [95% CI]: 1.882 [1.596, 2.220]) and non-COVID-19 mortality (791.6 vs. 588.4 deaths per 100,000 persons; OR [95% CI]: 1.356 [1.303, 1.412]). Negative control outcomes did not show any indication of meaningful unobserved residual confounding.

Conclusion Florida adults who received BNT162b2 had significantly higher risk of 12-month all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to matched mRNA-1273 recipients. These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend b




https://publichealthpolicyjournal.com/florida-study-reveals-elevated...

In a landmark analysis conducted by researchers at MIT and the Florida Department of Health, a rigorously matched cohort study (preprint, not reviewed) of over 1.4 million adult residents of Florida has revealed that individuals who received the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) experienced significantly higher mortality over the following 12 months than those who received Moderna’s mRNA-1273. Drawing on Florida’s comprehensive state health records, this study is the most detailed comparative examination to date of the long-term, all-cause mortality impact of the two mRNA vaccines—and its findings raise urgent and fundamental questions about vaccine safety, oversight, and policy.

Share

All-Cause Mortality — A Signal That Won’t Stay Quiet
At the heart of the Florida Department of Health study is a sobering result: the vaccine that dominated early national rollout campaigns—Pfizer’s BNT162b2—was associated with a substantially higher risk of death from any cause within one year of vaccination than Moderna’s mRNA-1273.

This wasn’t a marginal or abstract difference. Among matched pairs of 735,050 adults for each vaccine type—matched on age, sex, race, ethnicity, census tract, vaccination month, and vaccination site—those who received the Pfizer vaccine experienced:

847.2 deaths per 100,000 people, compared to

617.9 deaths per 100,000 in the Moderna group.

That’s 229 excess deaths per 100,000 individuals—a 37% higher risk of all-cause mortality over 12 months (Odds Ratio: 1.384, 95% CI: 1.331 to 1.439).


Top of the page Bottom of the page


Jump to forum :
Search this forum
Printer friendly version
E-mail a link to this thread

(Delete cookies)